Jazz Seeks Second-Line Lurbinectedin SCLC Withdrawal

Published Date: 08 Aug 2026

The planned label change follows failure of lurbinectedin to improve overall survival in the phase 3 postmarketing trial; the first-line maintenance indication remains unaffected.

Read Full News

Latest News

Gatekeeping May Reduce Pediatric Cancer Trial Participation

Researchers query parents of children with cancer and clinicians on barriers and facilitators to participation in clinical trials.

AI Framework Helps Classify Renal Tumors, Predict Outcomes

A deep learning system trained on whole-slide images classifies nine renal tumor subtypes with high accuracy and outperforms traditional grading in predicting patient outcomes.

Dual Checkpoint Blockade Boosts Breast Cancer pCR

Patients with high-risk ERBB2-negative breast cancer receive dual checkpoint blockade with cemiplimab and fianlimab in addition to standard neoadjuvant chemotherapy.

Breast Density Laws Fall Short Raising Additional Screening

State mandates requiring insurance coverage for additional breast cancer scans for those with dense breasts are failing to boost usage.

Is Shorter Radiation Linked to Lymphedema in Breast Cancer?

A trial tests whether 40Gy in 15 fractions over 3 weeks leads to more arm lymphedema than 50Gy in 25 fractions over 5 weeks.

Defibrotide Prophylaxis May Reduce SOS Risk After HSCT

A study evaluates whether defibrotide prophylaxis during HSCT reduces the risk for sinusoidal obstruction syndrome in children with relapsed or refractory B-ALL receiving prior inotuzumab.

Todays Updates

Erythematous Infiltrated Papules and Plaques on the Forehead

A 32-year-old woman presented to the dermatology department with asymptomatic raised, reddish lesions on the right forehead of 5 months’ duration.

Denosumab May Protect Joints in Adults With Osteoporosis

Starting denosumab is associated with a modestly lower risk of developing osteoarthritis than starting oral bisphosphonates among adults with osteoporosis.

Fluctuations in Sleep Patterns Common in Schizophrenia

Variability in sleep efficiency and time in bed is increased in individuals at clinical high risk for psychosis or with schizophrenia spectrum disorders, new research shows.

Annual Wellness Visits May Help Flag Cognitive Issues

Annual wellness visits are linked to an increased chance of diagnosis of mild cognitive impairment.

Sleep Disorders Common in Medication Overuse Headache

Sleep disorders are more common in people with medication overuse headache than in those without the condition, with MOH treatment improving sleep, a study shows.

Psilocybin-Assisted Tx Shows Early Promise in Severe PTSD

Three quarters of veterans with severe, treatment-resistant PTSD achieve remission at 1 month after psilocybin-assisted therapy in a small pilot study.

Atogepant Outperforms Topiramate for Migraine Prevention

Atogepant shows better tolerability and efficacy than topiramate for migraine prevention in a phase 3b trial comparing the drugs.

Todays Updates

Erythematous Infiltrated Papules and Plaques on the Forehead

A 32-year-old woman presented to the dermatology department with asymptomatic raised, reddish lesions on the right forehead of 5 months’ duration.

Denosumab May Protect Joints in Adults With Osteoporosis

Starting denosumab is associated with a modestly lower risk of developing osteoarthritis than starting oral bisphosphonates among adults with osteoporosis.

Fluctuations in Sleep Patterns Common in Schizophrenia

Variability in sleep efficiency and time in bed is increased in individuals at clinical high risk for psychosis or with schizophrenia spectrum disorders, new research shows.

Annual Wellness Visits May Help Flag Cognitive Issues

Annual wellness visits are linked to an increased chance of diagnosis of mild cognitive impairment.

Sleep Disorders Common in Medication Overuse Headache

Sleep disorders are more common in people with medication overuse headache than in those without the condition, with MOH treatment improving sleep, a study shows.

Psilocybin-Assisted Tx Shows Early Promise in Severe PTSD

Three quarters of veterans with severe, treatment-resistant PTSD achieve remission at 1 month after psilocybin-assisted therapy in a small pilot study.

Atogepant Outperforms Topiramate for Migraine Prevention

Atogepant shows better tolerability and efficacy than topiramate for migraine prevention in a phase 3b trial comparing the drugs.

Latest News

Researchers query parents of children with cancer and clinicians on barriers and facilitators to participation in clinical trials.

A deep learning system trained on whole-slide images classifies nine renal tumor subtypes with high accuracy and outperforms traditional grading in predicting patient outcomes.

Patients with high-risk ERBB2-negative breast cancer receive dual checkpoint blockade with cemiplimab and fianlimab in addition to standard neoadjuvant chemotherapy.

State mandates requiring insurance coverage for additional breast cancer scans for those with dense breasts are failing to boost usage.

A trial tests whether 40Gy in 15 fractions over 3 weeks leads to more arm lymphedema than 50Gy in 25 fractions over 5 weeks.

A study evaluates whether defibrotide prophylaxis during HSCT reduces the risk for sinusoidal obstruction syndrome in children with relapsed or refractory B-ALL receiving prior inotuzumab.

News All Time

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup

A recent trial assesses whether the addition of quizartinib following intensive chemotherapy improves survival outcomes in older patients with previously untreated AML.

FDA Approves New ROS1 Inhibitor for NSCLC

The newly approved inhibitor is for patients who previously received another drug of the same class.

Patients With Early-Onset Cancer Unaware of Infertility Risk

Many patients with early-onset cancer say they were never told that treatments could affect their fertility.

Virtual Help Doubles Cancer Patients’ Smoking Quit Rate

Programs offering telehealth counseling and nicotine replacement products should be part of routine oncology care, researchers say.

MRD Tied to PFS in Lymphoma Patients on Epcoritamab

Researchers evaluate minimal residual disease status in 128 adults with relapsed or refractory follicular lymphoma treated with epcoritamab.

Germline Profiling May Improve Risk Stratification in t-MNs

A new study explores whether germline profiling could refine the subclassification and prognosis of therapy-related myeloid neoplasms beyond treatment history alone.

Body Clock Genes Tied to Prostate Radiotherapy Toxicity

Could timing prostate cancer radiotherapy according to patients’ circadian rhythm genes reduce the risk for late side effects?

Gedatolisib Combo Approved for Advanced Breast Cancer

Progression-free survival with the multitarget PAM inhibitor approaches 10 months after anti-CDK4/6 and aromatase inhibitor failure.

Lung Transplant for Lung Cancer: Promising, in Rare Cases

In a small single-center study, 1-year survival is 100% among carefully selected patients who undergo bilateral lung transplantation for stage IV disease confined to the lungs.

MGRS Relapse-Free Survival Better With Maintenance Therapy

Researchers retrospectively analyzed outcomes for 50 patients with biopsy-proven monoclonal gammopathy of renal significance for a median follow-up of 6.15 years.

Race, Geography Linked to Gaps in Prostate Cancer Care

A US government study finds racial disparities in care and a complicated relationship between distance to major cancer centers and patients’ treatment and outcomes.

PPI, Antibiotics May Curb Durvalumab Efficacy in NSCLC

Study adds to evidence that the widely used medications may interfere with immunotherapy efficacy via effects on the gut microbiome.

FDA Approves Subcutaneous Isatuximab for MM Indications

The drug can now be administered with the hands-free automated CirCLIQ on-body injector.

AI-Driven Biomarker Predicts Prostate Cancer Outcomes

The tool, based on histology only, may help identify patients most likely to benefit from triplet therapy.

Community Oncology Well Suited for Advanced Cancer Patients

Experts tout common characteristics of local physician practices that are beneficial to those with advanced disease.

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

A retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in patients with metastatic urothelial carcinoma.

Recommended News For You

PSA Screening Overdiagnosis Rises Sharply With Age

According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.

New imaging guidelines for head and neck cancers, a step toward practice change

Traces of bacteria inside brain tumors may affect tumor behavior

Blinatumomab May Improve Survival in High-Risk Adult B-ALL

FDA approves Blenrep for relapsed or refractory multiple myeloma

Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma

Recommended Articles For You

Advanced Breakthroughs in Hematology and Patient Outcomes 

Comprehensive Techniques in Hematology in Clinical Decision-Making 

The Next Generation of Precision: How Multi-Specific Antibodies are Redefining Oncology's Future - A 2025 Review 

A Closer Look at White Blood Cells in Urine: Uncovering the Causes and Treatments 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Studies have shown that physical activity prevents cancer in patients who have been treated for cancer in the past.

2.

The amount of liver tissue removed during gallbladder surgery has no discernible impact on overall survival.

3.

Oncologist on Hantavirus Cruise; Bile Duct Cancer Drug OK'd; Untreated Lung Cancers

4.

Trial Supports Ivonescimab and Chemo for NSCLC Survival

5.

Hereditary cancer has a rare and underreported cause.

1.

Unlocking Immunity: TILs, Immunotherapy Biomarkers, and Toxicity Management in Oncology

2.

New Research on Craniopharyngioma 

3.

Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies

4.

The Ultimate Guide to Understanding Abiraterone and its Uses in Cancer Treatment 

5.

All About Ferric Gluconate – The Best Source Of Iron For Anemia

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

1.

Early Cancer Detection Saves Lives

2.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective

3.

Thromboprophylaxis In Medical Settings- An Update

4.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

5.

Efficient Management of First line ALK-rearranged NSCLC - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot